Skip to main content
Premium Trial:

Request an Annual Quote

454, Malaysian Genomics Center Team on Sequencing Projects

NEW YORK (GenomeWeb News) — The Malaysian Genomics Resource Center will use 454 Life Sciences’ GS FLX sequencer in genomics and bioinformatics projects studying tropical diseases and organisms, 454 said today.  
 
454 said it will work with the MGRC on a number of "high-profile" projects with the Malaysian academic community.
 
The company said these projects include sequencing microbes with biotechnological and medical applications, as well as large-scale characterization of diseases that are prevalent in Malaysia and the surrounding region.
 
"Malaysia is investing significant resources in establishing itself as a regional hub for biotechnology research and industrialization," 454 President and CEO Christopher McLeod said in a statement.
 
By working with the MGRC, 454 aims to realize the “full potential of genomics in Malaysia,” McLeod said.
 
The MGRC is supported by the Malaysian Biotechnology Corporation, which operates under the Malaysian Ministry of Science, Technology, and Innovation.
 
It was not immediately clear whether 454 will install a GS FLX at the MGRC, or perform sequencing services at its own facility.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.